Ligand validation:5OSC

Y01: CHOLESTEROL HEMISUCCINATE

Y01 is a Ligand Of Interest in 5OSC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5OSC_Y01_B_506	2%	49%	0.485	0.791	0.61	1.33	-	7	0	0	100%	1
5OSC_Y01_B_505	1%	37%	0.546	0.756	0.71	1.73	-	15	0	0	100%	1
5OSC_Y01_E_505	1%	47%	0.612	0.783	0.64	1.39	-	9	1	0	100%	1
5OSC_Y01_A_504	0%	48%	0.695	0.76	0.62	1.38	-	9	2	0	100%	1
5OSC_Y01_D_505	0%	50%	0.89	0.781	0.62	1.29	-	7	0	0	100%	1
5OSA_Y01_E_505	15%	50%	0.3	0.862	0.61	1.32	-	7	0	0	100%	1
2Y00_Y01_B_401	50%	23%	0.195	0.946	1.24	1.91	3	14	1	0	100%	1
2Y01_Y01_A_401	49%	25%	0.208	0.956	1.24	1.82	3	15	1	0	100%	1
2Y03_Y01_B_401	48%	23%	0.213	0.957	1.21	1.97	3	13	2	0	100%	1
3ZPR_Y01_A_401	47%	16%	0.215	0.956	1.23	2.42	3	13	1	0	100%	1
4XNV_Y01_A_1103	46%	26%	0.175	0.911	1.87	1.17	9	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.